The subcutaneous administration of 0.01–10 mg/kg of the antiallergic agent disodium cromoglycate on day 0 30 min prior to sensitization of C57B1/6 male mice with 5% 2-phenyl-4-ethoxy-methylene oxazolone proved to cause a significant stimulation of the low-grade leg volume response as measured plethysmographically 24 h after challenge. The investigation of the mechanism favors the conclusion that histamine release is involved in the action of disodium cromoglycate as judged by the ability of the antihistaminics chlorpheniramine and metiamide to inhibit the disodium cromoglycate action and by the inhibitory effect of polymyxin B induced depletion of histamine.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.